MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
PHAT
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Phathom Pharmaceuticals (PHAT) Ownership - Who owns Phathom Pharmaceuticals?

Phathom Pharmaceuticals Inc operates as a clinical-stage biopharmaceutical company... Show more

#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
N/A
Address
100 Campus Drive
Phone
+1 877 742-8466
Employees
371
Web
https://www.phathompharma.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
852.59M
P/E Ratio
N/A
Total Cash
180.9M
Projected Growth
N/A
Total Debt
166.3M
Revenue
204.89M
Risk (Beta)
1.75
Dividend Yield
N/A
Total Cash/Share
2.27
Total Debt/Equity
N/A
Revenue/Share
2.72 USD as % of share price
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
PHAT
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
View AI-Driven Trading for PHAT
A.I. Advisor
published General Information

General Information

a biopharmaceutical company, which focuses on the development and commercialization of novel treatments for gastrointestinal diseases and disorders

Industry Biotechnology

Profile
Details
Industry
N/A
Address
100 Campus Drive
Phone
+1 877 742-8466
Employees
371
Web
https://www.phathompharma.com